1. Home
  2. RDHL vs JCSE Comparison

RDHL vs JCSE Comparison

Compare RDHL & JCSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • JCSE
  • Stock Information
  • Founded
  • RDHL 2009
  • JCSE 1999
  • Country
  • RDHL Israel
  • JCSE Singapore
  • Employees
  • RDHL N/A
  • JCSE N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • JCSE Miscellaneous manufacturing industries
  • Sector
  • RDHL Health Care
  • JCSE Consumer Discretionary
  • Exchange
  • RDHL Nasdaq
  • JCSE Nasdaq
  • Market Cap
  • RDHL 3.8M
  • JCSE 5.9M
  • IPO Year
  • RDHL N/A
  • JCSE 2022
  • Fundamental
  • Price
  • RDHL $2.02
  • JCSE $1.14
  • Analyst Decision
  • RDHL
  • JCSE
  • Analyst Count
  • RDHL 0
  • JCSE 0
  • Target Price
  • RDHL N/A
  • JCSE N/A
  • AVG Volume (30 Days)
  • RDHL 19.3K
  • JCSE 6.5K
  • Earning Date
  • RDHL 08-28-2025
  • JCSE 05-15-2025
  • Dividend Yield
  • RDHL N/A
  • JCSE 7.89%
  • EPS Growth
  • RDHL N/A
  • JCSE N/A
  • EPS
  • RDHL N/A
  • JCSE 0.00
  • Revenue
  • RDHL $8,042,999.00
  • JCSE $14,126,397.00
  • Revenue This Year
  • RDHL $381.91
  • JCSE N/A
  • Revenue Next Year
  • RDHL N/A
  • JCSE N/A
  • P/E Ratio
  • RDHL N/A
  • JCSE $247.98
  • Revenue Growth
  • RDHL 23.17
  • JCSE 6.92
  • 52 Week Low
  • RDHL $1.71
  • JCSE $0.70
  • 52 Week High
  • RDHL $20.28
  • JCSE $2.39
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 57.04
  • JCSE 50.53
  • Support Level
  • RDHL $1.75
  • JCSE $1.11
  • Resistance Level
  • RDHL $2.08
  • JCSE $1.17
  • Average True Range (ATR)
  • RDHL 0.10
  • JCSE 0.04
  • MACD
  • RDHL 0.03
  • JCSE -0.00
  • Stochastic Oscillator
  • RDHL 85.16
  • JCSE 35.29

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.

About JCSE JE Cleantech Holdings Limited

JE Cleantech Holdings Ltd is engaged in the manufacturing and selling of cleaning systems and other equipment that can be categorized into four different categories, namely aqueous washing systems, plating and cleaning systems, train cleaning systems, and other equipment, such as filtration units. The product lives of its cleaning systems and other equipment ranges from two to ten years. The company is also into designing, developing, and manufacturing other cleaning systems for various industrial end-use applications using its R&D and engineering capabilities. The company derives the majority of its revenue from the Sales of cleaning systems and other equipment. Geographically, the company derives a majority of its revenue from Singapore, followed by Malaysia.

Share on Social Networks: